Caricamento...
Molecular Mechanisms and Therapeutics for SCA17
Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. Like other polyQ expansion-mediated diseases, SCA17 is characterized by late-onset and selective neurodegeneration, despite th...
Salvato in:
| Pubblicato in: | Neurotherapeutics |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985407/ https://ncbi.nlm.nih.gov/pubmed/31317427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00762-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|